BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8049418)

  • 1. [Morphologic changes of erythrocytes in mice and rats exposed to organophosphate cholinesterase inhibitors].
    Prozorovskiĭ VB; Skopichev VG
    Biull Eksp Biol Med; 1993 Apr; 115(4):443-5. PubMed ID: 8049418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythrocyte structural changes as a possible reason for the low effectiveness of specific therapy for carbophos poisoning].
    Prozorovskiĭ VB; Skopichev VG; Ardab'eba TV; Panov PB
    Morfologiia; 1997; 112(6):60-4. PubMed ID: 9511154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Arafat K; Rajan S; Hasan MY
    Arch Toxicol; 2006 Nov; 80(11):777-84. PubMed ID: 16598495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
    Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
    Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
    Petroianu GA; Hasan MY; Nurulain SM; Shafiullah M; Sheen R; Nagelkerke N
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):312-6. PubMed ID: 17040217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The distant effects of acetylcholine--links in the pathogenesis of poisoning by cholinesterase inhibitors].
    Skopichev VG; Prozorovskiĭ VB
    Eksp Klin Farmakol; 1999; 62(2):10-1. PubMed ID: 10340119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continual determination of acetylcholinesterase inhibition following organophosphate poisoning using an auto analyzer.
    Bajgar J; Fusek J; Patocka J; Hrdina V
    Acta Biol Med Ger; 1977; 36(2):231-6. PubMed ID: 906734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microcirculatory changes in poisoning by phosphoorganic cholinesterase inhibitors].
    Gromov AE; Rozengart VI
    Biull Eksp Biol Med; 1976 Jan; 81(1):28-30. PubMed ID: 1247670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organophosphate poisoning--an overview.
    Koelle GB
    Fundam Appl Toxicol; 1981; 1(2):129-34. PubMed ID: 7184779
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of intoxication with GV compound in laboratory rats.
    Fusek J; Bajgar J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1994; 37(2):57-62. PubMed ID: 7784799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antagonism of phosphorus-containing heterocyclics with the anticholinesterase agent Phosphacol (paraoxon)].
    Garaev RS
    Eksp Klin Farmakol; 1996; 59(1):68-70. PubMed ID: 8704640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromyography in relation to end-plate acetylcholinesterase in rats poisoned by different organophosphates.
    De Bleecker J; Van den Abeele K; De Reuck J
    Neurotoxicology; 1994; 15(2):331-40. PubMed ID: 7991222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on monitoring and clearing of organophosphate in blood in organophosphate poisoned rats].
    Zhang J; Zhao J; Zheng Y; Shao X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Dec; 20(6):413-5. PubMed ID: 14694586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fulminant coma as the first manifestation of organophosphate poisoning].
    Rodríguez-Borregán JC; Miñambres E; Tejero MA; Rebollo M
    Neurologia; 2002 Mar; 17(3):173-5. PubMed ID: 11927111
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
    Hasan MY; Nurulain SM; Arafat K; Naseer OP; Petroianu GA
    J Appl Toxicol; 2004; 24(4):257-60. PubMed ID: 15300712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Finding cholinesterase in endotheliocytes: cholinesterase inhibition by organophosphorus compounds leads to endotheliocyte deformation].
    Prozorovskiĭ VB; Skopichev VG
    Eksp Klin Farmakol; 2005; 68(3):64-7. PubMed ID: 16047685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of an electrometric method for measurement of blood cholinesterase activities in sheep, goats and cattle treated with organophosphate insecticides.
    Mohammad FK; Alias AS; Faris GA; Al-Baggou BKh
    J Vet Med A Physiol Pathol Clin Med; 2007 Apr; 54(3):140-3. PubMed ID: 17381678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Participation of a distant cholinergic mechanism in the response of the vascular bed to intoxication by organophosphorus inhibitors of cholinesterase].
    Skopichev VG; Prozorovskiĭ VB; Medvedeva SV
    Morfologiia; 2000; 118(4):66-9. PubMed ID: 12629810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nitric oxide in regulation of deformability of red blood cells in acute phase of endotoxaemia in rats.
    Starzyk D; Korbut R; Gryglewski RJ
    J Physiol Pharmacol; 1997 Dec; 48(4):731-5. PubMed ID: 9444620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.